Hutchison China MediTech Limited
-
Ticker
HCM
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 501-1000 Employees
- Based in Central, Hong Kong
Hutchison China MediTech Limited, known as Chi-Med, is an innovative biopharmaceutical company aiming to become a global leader in the discovery, development and commercialisation of targeted therapies and immunotherapies in oncology and immunological diseases.
Hutchison China MediTech Limited
Most Recent Responsibility Report
MOST RECENT
2023 Sustainability Report
Report Locked. Hutchison China MediTech Limited has reached its limit for free report views.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Hutchison China MediTech Limited Sustainability Report, Hutchison China MediTech Limited Corporate Social Responsibility Report, Hutchison China MediTech Limited CSR Report, Hutchison China MediTech Limited Corporate Responsibility, Hutchison China MediTech Limited CR Report, Hutchison China MediTech Limited Citizenship Report, Hutchison China MediTech Limited ESG Report, and Hutchison China MediTech Limited Environmental Report online.